Company Filing History:
Years Active: 1998-2003
Title: Innovations in Retinoid Research: The Contributions of Steve White
Introduction
Steve White is an influential inventor based in San Diego, California. He holds two notable patents that focus on compounds and methods for modulating processes mediated by Retinoid X Receptors (RXRs). His innovative work demonstrates the potential for advancements in the pharmaceutical industry.
Latest Patents
Steve White's latest patents include:
1. **Compounds having selective activity for retinoid X receptors** - This patent outlines compounds, compositions, and methods to modulate processes mediated by Retinoid X Receptors selectively, emphasizing the preference for RXRs over Retinoic Acid Receptors (RARs). Examples of the compounds covered are bicyclic benzyl, pyridinyl, thiophene, furanyl, pyrrole, and polyenoic acid derivatives, including carbocyclic polyenoic acids.
2. **Means for modulation of processes mediated by Retinoid X Receptors** - Similar in focus, this patent details the methodologies employed using retinoid-like compounds that selectively influence RXRs. The strategies offered are critical for furthering understanding and application of retinoid functionalities in therapeutic settings.
Career Highlights
Steve White is associated with Ligand Pharmaceuticals, Inc., a company known for its cutting-edge research and development in the life sciences sector. His contributions have significantly advanced understanding in the field of retinoid biology, leading to potential therapeutic applications.
Collaborations
Throughout his career, Steve White has collaborated with notable colleagues such as Marcus F Boehm and Richard Alan Heyman. These partnerships have facilitated the exchange of ideas and enhanced the research outcomes in their respective fields of study.
Conclusion
Steve White's innovative work in the area of Retinoid X Receptors exemplifies the profound impact that dedicated inventors can have on science and medicine. His patents pave the way for future developments that could revolutionize therapeutic approaches, benefitting both the medical community and patients alike.